Evidence map›Paper›PMID 38123318›Full record

ArticleBMJ case reports2023

Encephalitis as an initial presentation of type 2 amiodarone-induced thyrotoxicosis.

Kyle Cilia, Simon Mifsud, Sarah Craus, Sandro Vella, Nicola Dingli

Open access · greenAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in BMJ case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kyle CiliaDepartment of Diabetes and Endocrinology, Mater Dei Hospital, Msida, Malta kyle.a.cilia@gov.mt.ORCID http://orcid.org/0000-0002-7125-736X
Simon MifsudDepartment of Diabetes and Endocrinology, Mater Dei Hospital, Msida, Malta.
Sarah CrausDepartment of Diabetes and Endocrinology, Mater Dei Hospital, Msida, Malta.
Sandro VellaDepartment of Diabetes and Endocrinology, Mater Dei Hospital, Msida, Malta.
Nicola DingliDepartment of Neuroscience, Mater Dei Hospital, Msida, Malta.
Mater Dei Hospital · MT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of a woman in her mid-20s presenting with encephalitis as the initial presentation of type 2 amiodarone-induced thyrotoxicosis (AIT). She was on amiodarone in view of a history of hypertrophic cardiomyopathy. Symptomatology included acute personality change and focal myoclonic jerks.Cerebrospinal fluid analysis showed a non-specific protein count elevation with negative microbiology, virology, autoimmune screen and onconeural antibodies. The electroencephalogram was consistent with a generalised cerebral dysrhythmia. An MRI of the head revealed symmetrical oedema within the motor cortices and a high T2 signal within the cerebellar dentate nuclei, with no restricted diffusion. Blood investigations confirmed thyrotoxicosis with negative antithyroid antibodies. She did not fulfil the criteria for a thyroid storm. Other possible causes of encephalitis were excluded.There was an excellent clinical, laboratory and radiological response to glucocorticoids, suggesting a diagnosis of steroid-responsive encephalitis secondary to type 2-AIT in the absence of a thyroid storm.

Indexed as

AmiodaroneThyroid CrisisThyrotoxicosisAdultAnti-Arrhythmia AgentsFemaleHumansAmiodaroneAnti-Arrhythmia AgentsEndocrinologyNeurologyThyroid disease

Identifiers

PMID38123318
OpenAlexW4390033947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.